Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 3/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.38 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.38 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6261842 | 1.00 | ADORA2A (0.42) | ADORA2AADORA1ADORA3CYP1A2MAOA | |
| SCHEMBL28830792 | 0.98 | ADORA2A (0.41) | ADORA2AADORA1ADORA3CYP1A2MAOA | |
| Acetaldehyde SCHEMBL4861152 | 0.88 | MAOA (0.39) | ADORA2AADORA1ADORA3CYP1A2MAOA | |
| SCHEMBL11210839 | 0.84 | MAOA (0.41) | ADORA2AADORA1ADORA3MAOAMEN1 | |
| SCHEMBL29011348 | 0.76 | EED (0.43) | — | |
| SCHEMBL34470674 | 0.73 | TSHR (0.36) | MEN1KMT2ANPC1L3MBTL1 | |
| SCHEMBL288995 | 0.71 | MEN1 (0.38) | CYP1A2MEN1KMT2ATDP1NPC1 | |
| SCHEMBL104411 | 0.71 | MEN1 (0.38) | CYP1A2MEN1KMT2ATDP1NPC1 | |
| SCHEMBL276858 | 0.71 | MEN1 (0.38) | CYP1A2MAOAMEN1KMT2AMAOB | |
| SCHEMBL2589546 | 0.71 | MEN1 (0.38) | CYP1A2MEN1KMT2ACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 505 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109879839-B | 6-piperazinemethyl-7-hydroxy benzofuran compound and medical application thereof | 沈阳大学 | 2023-04-25 | — | — | CN | claimed |
| CN-113122062-A | Quantum dot ink and preparation method of quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| US-10689396-B2 | Inhibitors of Bruton's tyrosine kinase and methods of their use | JANSSEN PHARMACEUTICA NV (BE) | 2020-06-23 | — | — | US | claimed |
| EP-3386992-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE | Janssen Pharmaceutica, N.V. (BE) | 2018-10-17 | — | — | EP | claimed |
| WO-2018103058-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE | JANSSEN PHARMACEUTICA NV (BE) | 2018-06-14 | — | — | WO | claimed |
| US-20170283431-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE | JANSSEN PHARMACEUTICA NV (BE) | 2017-10-05 | — | — | US | claimed |
| WO-2017100668-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE | JANSSEN PHARMACEUTICA NV (BE) | 2017-06-15 | — | — | WO | claimed |
| WO-2016154694-A1 | N-ACYLHYDRAZONE COMPOUNDS INHIBITING HISTONE DESACETYLASE ENZYMES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHOD FOR PRODUCING SAME | UNIVERSIDADE FEDERAL DO RIO DE JANEIRO-UFRJ (BR) | 2016-10-06 | — | — | WO | claimed |
| US-8067583-B2 | Method for synthesizing furanosteroids | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2011-11-29 | — | — | US | claimed |
| CN-101412775-B | Catalyst precursor for polymerization of propylene or combined polymerization, and preparation thereof | BEIJING JINDINGKE CHEMICAL TECHNOLOGY CO LTD | 2010-12-22 | — | — | CN | claimed |
| CN-101139407-B | Catalyst precursor for ethylene polymerization or copolymerization and preparation method thereof | BEIJING JINDINGKE CHEMICAL TECHNOLOGY CO LTD | 2010-10-06 | — | — | CN | claimed |
| US-20090143346-A1 | Method for synthesizing furanosteroids | TRUSTEES OF DARTMOUTH COLLEGE | 2009-06-04 | — | — | US | claimed |
| CN-101412775-A | Catalyst activity component for polymerization of propylene or combined polymerization, catalyst precursor containing the same and preparation thereof | BEIJING JINDINGKE CHEMICAL TEC (CN) | 2009-04-22 | — | — | CN | claimed |
| CN-101139407-A | Catalyst active component for ethylene polymerization or copolymerization and catalyst precursor comprising the active component and preparation method thereof | BEIJING JINDINGKE CHEMICAL TEC (CN) | 2008-03-12 | — | — | CN | claimed |
| EP-0506549-B1 | Dyeing composition for keratinous fibers containing oxidation dye precursors and hydroxybenzofurans as couplers and dyeing process making use of such a composition | OREAL (FR) | 1995-10-18 | — | — | EP | claimed |
| US-5203875-A | Hair dyes also using ortho- and para-phenylenediamines or aminophenols; colorfastness; washfastness; perspiration resistance | L'OREAL (FR) | 1993-04-20 | — | — | US | claimed |
| US-20260092045-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2026-04-02 | — | — | US | disclosed |
| US-12570643-B2 | 3-aryloxy-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof | SHANGHAI LEADO PHARMATECH CO. LTD. (CN) | 2026-03-10 | — | — | US | disclosed |
| US-3931240-A | ANTIDEPRESSANT, ANTIAGGRESSION | LABAZ (FR) | 1976-01-06 | — | — | US | disclosed |
| US-3931298-A | FROM A HYDROXYAROMATIC AND AMMONIA, GROUP 8-CYCLOHEXANONE CATALYST | ETHYL CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10689396-B2 | Inhibitors of Bruton's tyrosine kinase and methods of their use | ABL1, BTK, MYLK2 | ADORA2A 3876/4885ADORA1 4495/4885ADORA3 4281/4885 |
| US-20260092045-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | TFPI, F3, BTK | ADORA2A 3061/4885ADORA1 3199/4885ADORA3 2966/4885 |
| US-20170283431-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE | ABL1, BTK, MYLK2 | ADORA2A 3900/4885ADORA1 4527/4885ADORA3 4303/4885 |
| US-20090143346-A1 | Method for synthesizing furanosteroids | HSD17B7, HSD17B13, CYP17A1 | ADORA2A 2951/4885ADORA1 2198/4885ADORA3 1396/4885 |
| US-12570643-B2 | 3-aryloxy-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof | TRPA1, TRPM7, TRPV1 | ADORA2A 404/4885ADORA1 166/4885ADORA3 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.